The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...

The FDA has approved a re-engineered formulation of nilotinib with no mealtime restrictions for adult patients with newly ...

Kraft Heinz will have to go to court after a federal judge did not dismiss a class action lawsuit alleging the company lied ...

You can create a delicious Thanksgiving feast using simple ingredients catering to various dietary needs. Here’s a sample ...

We narrow down the most important market and consumer trends that could influence dairy product innovation in 2025.

New York, New York-- (Newsfile Corp. - November 15, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated ...

Donald Trump has recently appointed vaccine skeptic Robert F. Kennedy Jr. as his new health secretary.As per BBC, the ...

November 15, 2024) - The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Maryland on behalf of those who ...

Trump said would be his attorney general nominee. The House Ethics Committee had planned a vote on releasing the results of ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...